Congress shields radiation oncology from Medicare cost controls, raising taxpayer burden

What it does

This bill creates a new Medicare payment system for radiation oncology services that bundles payments per treatment episode rather than per individual service. It exempts this new program from budget-neutrality requirements (meaning savings don't trigger automatic payment cuts elsewhere), and it creates a legal safe harbor allowing radiation therapy providers to offer free or discounted transportation to patients without violating anti-kickback rules.

Why we flagged it

The bill's core mechanism is a bundled payment model for radiation oncology—a legitimate payment reform. However, the budget-neutrality exemption is a fiscal carve-out that shields the program from the normal cost-control mechanism applied to other Medicare innovations, effectively subsidizing the program at taxpayer expense.

What the text implies

• The budget-neutrality exemption (Section 5) means savings from the ROCR Program do not reduce other Medicare payment rates. This is a hidden fiscal cost: the program's efficiency gains are not recycled into the broader Medicare system, effectively creating a permanent subsidy for radiation oncology relative to other cancer treatments.
• The transportation add-on payment ($500–$510 per patient per episode) is conditioned on reporting ICD-10 code Z59.82 (transportation insecurity), but the bill does not mandate that providers screen for or report this code. Uptake and equity of the benefit depend entirely on provider discretion and patient disclosure, creating a hidden access disparity.

The full analysis lists 5 implications of this text.

Who stands to gain

radiation therapy providers and suppliers (hospital outpatient departments, physician groups, freest; radiation oncology equipment manufacturers (through stable, predictable payment environment); professional accreditation organizations (American College of Radiology, American College of Radiati